Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
Status:
NOT_YET_RECRUITING
Trial end date:
2028-02-28
Target enrollment:
Participant gender:
Summary
This is a crossover, randomized, double-blinded clinical pharmacology study enrolling dual cannabis-tobacco smokers to better understand the combined effects of co-administering cannabis and tobacco. The project aims to describe the pharmacokinetics and pharmacodynamics of marijuana-tobacco co-administration by delivering THC and nicotine in various combinations. This foundational study will establish a research program focused on elucidating the public health consequences of marijuana-tobacco co-use.
Phase:
PHASE2
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Food and Drug Administration (FDA) National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH)